Opportunity

Federal Register #FDA-2025-N-0002

FDA Regulatory Correction for Animal Drug Applications and Feeds

Buyer

Department of Health and Human Services / Food and Drug Administration

Posted

June 03, 2026

Identifier

FDA-2025-N-0002

This notice announces a regulatory correction by the Food and Drug Administration (FDA) regarding new animal drug applications and animal feeds. - Government Buyer: - Food and Drug Administration (FDA), Department of Health and Human Services - Scope of Correction: - Amends and corrects previous regulations for new animal drug applications and abbreviated new animal drug applications - Addresses technical errors in Title 21 CFR parts 520 and 558 - Affected Products (Referenced): - Lincomycin hydrochloride soluble powder (for swine, broiler chickens, honey bees) - Laidlomycin propionate potassium (for animal feeds) - Ractopamine (for animal feeds) - Notable Details: - No OEMs or vendors are named, as this is a regulatory update - No procurement of products or services is requested - Correction is effective immediately upon publication - Location: - Food and Drug Administration, 5001 Campus Drive, College Park, MD 20740

Description

The Food and Drug Administration (FDA) issued a final rule amending a previous final rule published on April 16, 2026. The original rule updated regulations related to new animal drug applications and abbreviated new animal drug applications for the last quarter of 2025. This amendment corrects inadvertent errors in the instructions for technical amendments. The rule is effective immediately upon publication and involves corrections to parts 520 and 558 of Title 21 CFR concerning animal drugs and feeds.

View original listing